Keith Ching is the Director of Computational Biology in Pfizers Oncology R&D unit. He focuses on developing innovative cancer therapies by using computational methods to analyze large-scale datasets, aiming to identify which patients will benefit from specific treatments. He holds a Ph. D. from San Diego State University.
As an alumnus of two California universities, UC Davis and San Diego State, Keith likely maintains connections to the state. His work in the San Diego area suggests a familiarity with the local community and culture. [Predicted] He may follow local collegiate and professional sports teams.
He was drawn to Pfizer by its "unparalleled amount of data" to advance personalized medicine.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.